If you're of South Asian origin — Indian, Pakistani, Bangladeshi, or Sri Lankan — and someone in your family has diabetes, high blood pressure, or kidney trouble, this article is for you. There's a pattern that repeats across our community on both sides of the world: a parent whose "sugar" was managed loosely for years, a blood pressure that was never quite controlled, and then, seemingly out of nowhere, a diagnosis of kidney disease that turns out to have been building silently for a decade. It rarely comes out of nowhere. This piece explains why South Asians carry higher kidney risk, the two simple tests that catch the problem early, what you can actually do about it — and, for NRI families, how to navigate all of this when your own care is in Canada and your parents' care is back in India.

Why South Asians are at higher risk

Chronic kidney disease — CKD — means the kidneys are gradually losing their ability to filter waste and fluid from the blood. Two conditions cause the large majority of it worldwide: type 2 diabetes and high blood pressure (hypertension). And these are exactly the two conditions South Asians develop at strikingly high rates.

South Asians tend to develop type 2 diabetes at a younger age and a lower body weight than the general population — the risk isn't explained by obesity alone. Insulin resistance appears earlier, and blood sugar runs high for longer before it's caught. High blood pressure is also common in the community and, culturally, is often under-treated: it produces no symptoms, so it's easy to ignore until it has already done damage to the small blood vessels of the kidney.

Put those two facts together — earlier, more aggressive diabetes plus common, under-treated hypertension — and you have the engine that drives higher CKD rates in South Asian populations. Diabetic kidney disease in particular tends to begin earlier and progress faster in South Asians than in many other groups, which means the window to intervene opens sooner and closes sooner too.

2
conditions — diabetes and high blood pressure — cause most chronic kidney disease
~90%
of people with early CKD don't know they have it — it's silent until advanced
2
tests catch it early: eGFR (blood) and urine albumin-to-creatinine ratio (ACR)

The diabetes–kidney connection, explained

The kidneys filter your blood through millions of tiny units called nephrons, each containing a delicate cluster of blood vessels. When blood sugar is high over years, it damages those small vessels — this is diabetic nephropathy, or diabetic kidney disease. The first measurable sign is usually not a rise in waste products, but a small leak: tiny amounts of the protein albumin begin to escape into the urine because the filter is no longer holding it back. This is why a urine test, not just a blood test, is essential — the leak shows up in the urine long before the blood work looks abnormal.

High blood pressure compounds the damage from the other direction, forcing blood through those already-stressed vessels at higher pressure. Diabetes and hypertension so often travel together that they accelerate each other, and the kidney sits in the crossfire.

The cruel feature of all this is that it's silent. Kidneys have enormous reserve capacity. You can lose half your kidney function — or more — and feel completely normal, with no pain, no obvious change in urination, nothing. Symptoms like swelling, fatigue, or foamy urine tend to appear only when the disease is well advanced and options have narrowed. That silence is precisely why screening, not waiting for symptoms, is the whole game.

The one thing to ask for

If you have diabetes, high blood pressure, or a family history of kidney disease, ask your GP for an eGFR blood test and a urine albumin-to-creatinine ratio (ACR) — at least once a year. These two inexpensive tests are the standard way to catch kidney disease while it's still silent and still treatable. If your numbers are borderline or falling, that's the moment to act, not later.

Know your numbers: eGFR and urine ACR

Two tests give the clearest picture of kidney health, and every South Asian adult with diabetes or hypertension should know both of their numbers.

eGFR — how well the kidneys are filtering

The estimated glomerular filtration rate (eGFR) is calculated from a simple blood creatinine test. Think of it as a percentage of normal filtering capacity: a healthy eGFR is around 90 or above. As it falls, kidney function is declining. An eGFR persistently below 60 points to chronic kidney disease and warrants closer attention. If your creatinine is up or your eGFR is down, our companion guide on what to do about a high creatinine result walks through the next steps.

Urine ACR — the early warning

The urine albumin-to-creatinine ratio (ACR) detects albumin — protein — leaking into the urine. Because this leak is one of the earliest signs of kidney damage, a raised ACR can flag trouble years before eGFR falls. It's the test most often skipped, and the one that catches diabetic kidney disease the earliest. A single abnormal result should be repeated to confirm it's a genuine trend and not a one-off.

What to do — the practical checklist

Kidney disease in South Asians is, to a large degree, preventable and slowable. The evidence-based steps are clear:

None of this is exotic. It's a matter of knowing you're at higher risk, getting the two tests, and acting on the numbers early — before the silent phase becomes the symptomatic one.

The NRI reality — managing kidney disease across two countries

For NRI families in Canada, there's a second layer to all of this that the standard advice never addresses. Many of us aren't only watching our own kidney numbers — we're simultaneously helping to manage an elderly parent back in India who already has chronic kidney disease, or who is on dialysis. And we're trying to do it from six thousand miles and eleven time zones away.

The decisions are hard and constant. A parent's creatinine has crept up — is it time to see a nephrologist, or is it the summer heat and dehydration? The doctor in India has suggested starting dialysis — is that the right call now, or is there room to hold off? Reports arrive on WhatsApp as blurry photos, half in medical shorthand, and you're expected to weigh in on a decision you don't have the context to judge. Meanwhile your own Canadian GP has just flagged that your eGFR is a little low, and you're waiting months for a nephrology referral of your own.

That is the specific, exhausting position Ginie Health was built to help with. We connect NRI families to nephrologists trained at PGIMER Chandigarh and AIIMS — specialists who understand both contexts. They can read the reports coming out of an Indian hospital in their native clinical language, and they can equally read your own Canadian labs. That dual fluency is rare and, for our community, enormously valuable.

In practice that means a nephrologist can review your elderly father's latest reports from India and tell you, in plain terms, whether the dialysis recommendation is reasonable or worth a second look — and separately review your own Canadian eGFR and urine ACR and tell you what they mean and what to push your GP for. One specialist, both sides of the family, both health systems.

A note on the wait — and how a specialist opinion fits

If your own Canadian kidney numbers are the concern, the public-system reality is that a nephrology referral takes time — often months. We cover the specifics in our master guide to nephrologist wait times across Canada, and the province-level detail in our guide to nephrologist wait times in BC. Those waits are exactly where a lot of quiet kidney damage progresses unmanaged.

A written specialist opinion doesn't replace your Canadian nephrologist — it makes the waiting time count. You upload your results (your eGFR, urine ACR, creatinine, blood pressure log — or a parent's reports from India) and describe the history. Within 6 hours, for $45 CAD, you receive a written clinical opinion from a nephrologist trained at PGIMER or AIIMS. For our community, those names mean something real — they're where many of our own relatives receive their care in India, so the credibility isn't marketing, it's familiar.

The opinion tells you what the numbers actually mean, which additional tests to request, whether a kidney-protecting medication like an SGLT2 inhibitor is worth discussing, and exactly what to say to your GP or at your eventual nephrology appointment — for yourself, or for a parent in India. If you'd rather talk it through, a live video consultation is available for $75 CAD. No referral required for either.